Genetic analysis and literature review of a Poirier–Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B
Open Access
- 30 November 2023
- journal article
- review article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 12 (1) , e2327
Abstract
Background: Poirier–Bienvenu neurodevelopmental syndrome (POBINDS) is a rare autosomal dominant neurologic disorder caused by a heterozygous variant of CSNK2B, which is characterized by early onset epilepsy, hypotonia, varying degrees of intellectual disability (ID), developmental delay (DD), and facial dysmorphism. This study clarifies the molecular diagnosis and causative factors of a Chinese boy with POBINDS.Methods: The clinical phenotypes and ancillary laboratory tests were collected and analyzed by trio whole exome sequencing (WES) and copy number variant sequencing (CNV‐seq) in the follow‐up proband's families. The candidate variant was validated by Sanger sequencing and bioinformatics software was used to further explore the effect of the de novo frameshift variant on the protein structure.Results: The proband carries a de novo frameshift variant c.453_c.454insAC (p.H152fs*76) in CSNK2B. According to the ACMG genetic variant classification criteria and guidelines, the locus is a pathogenic variant (PVS1+PS2+PM2) and the associated disease was POBINDS. Protein structure prediction suggests significant differences in amino acid sequences before and after mutation.Conclusion: A rare case of POBINDS caused by a novel frameshift variant in CSNK2B was diagnosed. The novel variant extends the variation spectrum of CSNK2B, which provides guidance for early clinical diagnosis, genetic counseling and treatment of this family. A review of the currently reported cases of POBINDS further enriches and summarizes the relationship between genotype and phenotype of POBINDS.Keywords
Funding Information
- National Key Research and Development Program of China (2016YFC1000307)
This publication has 22 references indexed in Scilit:
- Poirier–Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growthAmerican Journal of Medical Genetics Part A, 2020
- Germline de novo variants in CSNK2B in Chinese patients with epilepsyScientific Reports, 2019
- Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating NeuronsInternational Journal of Molecular Sciences, 2019
- Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizuresJournal of Human Genetics, 2019
- CSNK2B splice site mutations in patients cause intellectual disability with or without myoclonic epilepsyHuman Mutation, 2017
- Protein kinase CK2 in development and differentiationBiomedical Reports, 2016
- Channel-anchored Protein Kinase CK2 and Protein Phosphatase 1 Reciprocally Regulate KCNQ2-containing M-channels via Phosphorylation of CalmodulinJournal of Biological Chemistry, 2014
- CK2 negatively regulates GαssignalingProceedings of the National Academy of Sciences, 2009
- Casein kinase 2 as a potentially important enzyme in the nervous systemProgress in Neurobiology, 2000
- GTP plus water mimic ATP in the active site of protein kinase CK2.Nature Structural & Molecular Biology, 1999